Glucose-6-phosphate transporter gene therapy corrects metabolic and myeloid abnormalities in glycogen storage disease type Ib mice.
about
Liver transplantation in glycogen storage disease type ISLC transporters as therapeutic targets: emerging opportunitiesGlycogen storage disease type I and G6Pase-β deficiency: etiology and therapyCongenital neutropenia: diagnosis, molecular bases and patient management.Glycogen storage diseases: new perspectives.Specific reduction of hepatic glucose 6-phosphate transporter-1 ameliorates diabetes while avoiding complications of glycogen storage disease.Neutropenia in type Ib glycogen storage diseaseThe SLC37 family of phosphate-linked sugar phosphate antiporters.Esophageal Stricture Secondary to Candidiasis in a Child with Glycogen Storage Disease 1b.Gene therapy for type I glycogen storage diseasesEvidence for transcriptional regulation of the glucose-6-phosphate transporter by HIF-1alpha: Targeting G6PT with mumbaistatin analogs in hypoxic mesenchymal stromal cells.Normoglycemia alone is insufficient to prevent long-term complications of hepatocellular adenoma in glycogen storage disease type Ib mice.Medical management of chronic liver diseases in children (part I): focus on curable or potentially curable diseases.Inborn errors of metabolism underlying primary immunodeficiencies.Establishment and directed differentiation of induced pluripotent stem cells from glycogen storage disease type Ib patient.Maintenance of luminal NADPH in the endoplasmic reticulum promotes the survival of human neutrophil granulocytes.MT1-MMP down-regulates the glucose 6-phosphate transporter expression in marrow stromal cells: a molecular link between pro-MMP-2 activation, chemotaxis, and cell survival.The Physiopathological Role of the Exchangers Belonging to the SLC37 Family.
P2860
Q27013712-0866CA65-147C-471B-A3D4-5D068B84AD3AQ27014726-BF5C6D04-2B82-4C84-9FBD-6D9E05A6BE7FQ28296663-AB6945ED-58C6-43E0-BD79-3ED7C24F6D3AQ33395402-375EBA4D-A572-453F-BC54-2FC3127303BEQ34098766-F433AA3F-5482-4895-B41B-B4B14C7297EEQ34654019-EE3C9F3B-03C2-4136-B659-C15105B13888Q34996563-C4276709-CA9E-43B0-B42E-779299690CCDQ36700318-8024EB9D-69BD-4B8C-A9EE-E903FCCD66DCQ36768634-5726D5BA-42CA-4D3F-A10A-35C01F710E8CQ36789527-2765CA85-DDBA-4261-A961-6641433B9C3CQ37309846-2520A2E4-3E47-45F3-BAAC-A8C997D303EDQ37387718-0B03D2BD-C127-4CF0-A9AE-EB79D2014A27Q37945752-4681A3D3-E294-4619-B7D2-1C4B9AB8FBAEQ38235840-5916CB13-0B95-458B-9AC0-53A87D0D8751Q39242461-971894EE-DD05-4065-9B90-C89020A41847Q46601399-4E43A301-BFAA-4EF6-95B9-5D60B69238EAQ53576816-F3BCC13E-5769-4B5B-B59F-B23838E00479Q55032191-4023023F-32E9-44AB-940D-71AC48ED7812
P2860
Glucose-6-phosphate transporter gene therapy corrects metabolic and myeloid abnormalities in glycogen storage disease type Ib mice.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Glucose-6-phosphate transporte ...... storage disease type Ib mice.
@en
type
label
Glucose-6-phosphate transporte ...... storage disease type Ib mice.
@en
prefLabel
Glucose-6-phosphate transporte ...... storage disease type Ib mice.
@en
P2093
P2860
P356
P1433
P1476
Glucose-6-phosphate transporte ...... storage disease type Ib mice.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.GT.3302869
P577
2006-09-28T00:00:00Z